Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Banks, William A ^a,b   Niehoff, Michael L ^c   Ponzio, Nicholas M ^d   Erickson, Michelle A ^a,b,c   Zalcman, Steven S ^d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Blood brain barrier; Brain; Cellular trafficking; Encephalitis; Immune; Lymphocytes; Multiple sclerosis; Neuroimmune; Neuroinflammation; Pharmacokinetics

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; BIOLOGICAL MODEL; CELL ASSAY; CELL LABELING; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SPLEEN; TARGET ORGAN;

EID: 84866858942     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-231     Document Type: Article

References (30)

1. Yednock TA, Cannon C, Fritz LC, Sanchezmadrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992, 356:63-66. 10.1038/356063a0, 1538783.
2. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997, 158:3499-3510.
3. Pu H, Tian J, Flora G, Lee YW, Nath A, Hennig B, Toborek M. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol Cell Neurosci 2003, 24:224-237. 10.1016/S1044-7431(03)00171-4, 14550782.
4. Clausen F, Lorant T, Lewen A, Hillered L. T lymphocyte trafficking: a novel target for neuroprotection in traumatic brain injury. J Neurotrauma 2007, 24:1295-1307. 10.1089/neu.2006.0258, 17711391.
5. Emerich DF, Dean RL, Bartus RT. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp Neurol 2002, 173:168-181. 10.1006/exnr.2001.7835, 11771949.
6. Janigro D. Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier. Epilepsia 2012, 53(Supp 1):26-34.
7. Rezai-Zadeh K, Gate D, Town T. CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?. J Neuroimmune Pharmacol 2009, 4:462-475. 10.1007/s11481-009-9166-2, 2773117, 19669892.
8. Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011, 25:181-213. 10.1016/j.bbi.2010.10.015, 20970492.
9. Rook GA, Lowry CA, Raison CL. Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer. Brain Behav Immun 2011, 25:591-601. 10.1016/j.bbi.2010.12.005, 21167931.
10. Greenwood J, Heasman SJ, Alvarez JI, Pratt A, Lyck R, Engelhardt B. Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol 2011, 37:24-39. 10.1111/j.1365-2990.2010.01140.x, 20946472.
11. Etienne-Manneville S, Manneville JB, Adamson P, Wilbourn B, Greenwood J, Couraud PO. ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J Immunol 2000, 165:3375-3383.
12. Langer-Gould A, Steinman L. Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab. Curr Neurol Neurosci Rep 2006, 6:253-258. 10.1007/s11910-006-0013-z, 16635435.
13. Wolburg H, Wolburg-Buchholz K, Engelhardt B. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol 2005, 109:181-190. 10.1007/s00401-004-0928-x, 15549331.
14. Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 2008, 14:1555-1565. 10.2174/138161208784705432, 18673197.
15. Koyanagi Y, Tanaka Y, Kira J, Ito M, Hioki K, Misawa N, Kawano Y, Yamasaki K, Tanaka R, Suzuki Y, Ueyama Y, Terada E, Tanaka T, Miyasaka M, Kobayashi T, Kumazawa Y, Yamamoto N. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J Virol 1997, 71:2417-2424. 191352, 9032379.
16. Ching S, Zhang H, Lai W, Quan N. Peripheral injection of lipopolysaccharide prevents brain recruitment of leukocytes induced by central injection of interleukin-1. Neurosci 2006, 137:717-726.
17. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 1966, 13:655-669. 10.1111/j.1471-4159.1966.tb09873.x, 5950056.
18. Triguero D, Buciak J, Pardridge WM. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 1990, 54:1882-1888. 10.1111/j.1471-4159.1990.tb04886.x, 2338547.
19. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993, 47:169-176. 10.1016/0165-5728(93)90027-V, 8370768.
20. Samii A, Bickel U, Stroth U, Pardridge WM. Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J Physiol 1994, 267:E124-E131.
21. Feldman SH, Gografe SI, Kohn DF, Swindle MM. Laboratory Mouse Handbook 2006, Memphis: American Association for Laboratory Animal Science.
22. Kety SS. Cerebral circulation and its measurement by inert diffusible tracers. Encyclopedia of Neuroscience 1987, 206-208. Boston: Birkhäuser, Adelman G, I.
23. Ohno K, Pettigrew KD, Rapoport SI. Local cerebral blood flow in the conscious rat as measured with 14C-antipyrine, 14C-iodoantipyrine and 3H-nicotine. Stroke 1979, 10:62-67. 10.1161/01.STR.10.1.62, 432901.
24. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983, 3:1-7. 10.1038/jcbfm.1983.1, 6822610.
25. D'Agostino PM, Kwak C, Vecchiarelli HA, Toth JG, Miller JM, Masheeb Z, McEwen BS, Bulloch K. Viral-induced encephalitis initiates distinct and functional CD103+ CD11b+ brain dendritic cell populations within the olfactory bulb. Proc Natl Acad Sci USA 2012, 109:6175-6180. 10.1073/pnas.1203941109, 22474352.
26. Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 2012, 64:614-628. 10.1016/j.addr.2011.11.002, 22119441.
27. Chou S, Dix RD. Implications of the blood-brain barrier and its manipulation. Implications of the Blood-brain Barrier and Its Manipulation. Volume 2: Clinical Aspects 1989, 449-468. New York: Plenum Publishing Corporation, Neuwelt EA, 2.
28. Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nature Rev Immunol 2007, 7:904-912.
29. Desideri G, Ferri C. Endothelial activation: sliding door to atherosclerosis. Curr Pharm Des 2005, 11:2163-2175. 10.2174/1381612054367382, 16026286.
30. Hudson LC, Bragg DC, Tompkins MB, Meeker RB. Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells. Brain Res 2005, 1058:148-160. 10.1016/j.brainres.2005.07.071, 16137663.